Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 II, 1999, Pages

  Macnee, William ^a,b   Rahman, Irfan ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDIZING AGENT; PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1;

ANTIOXIDANT ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; DIET SUPPLEMENTATION; GENE EXPRESSION; HUMAN; INFLAMMATION; NEUTROPHIL; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INJURY;

EID: 0032719587     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.supplement_1.15     Document Type: Conference Paper

References (61)

1. Rahman, I., and W. MacNee, 1996. Role of oxidants/antioxidants in smoking-induccd lung diseases. Free Radic. Biol. Med. 21:669-681.
2. Church, T., and W. A. Pryor, 1985. Free-radical chemistry of cigarette smoke and its toxicological implications, Environ. Health Perspect. 64:111-126.
3. Abboud, R. T., T. Fera, A. Richter, M. Z. Tobona, and S. Johal. 1985. Acute effect of smoking on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 131:79-85.
4. Pryor, W. A., and K. Stone. 1993. Oxidants in cigarette smoke: radicals, hydrogen peroxides, peroxynitrate, and peroxynitrite. Ann. N.Y. Acad. Sci. 686:12-28.
5. Zang, L. Y., K. Stone, and W. A. Pryor. 1995. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic. Biol. Med. 19:161-167.
6. Morrison, D., I. Rahman, S. Lannan, and W. MacNee. 1999. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am. J. Respir. Crit. Care Med. 159:473-479.
7. Mateos, F., J. H. Brock, and J. L. Perez-Arellano. 1998. Iron metabolism in tile lower respiratory tract, Thorax 53:594-600.
8. Cantin, A., and R. G. Crystal. 1985, Oxidants, antioxidants and the pathogenesis of emphysema. Eur. J. Respir. Dis. 66(Suppl. 139):7-17.
9. Laurent, P., A. Janoff, and H. M. Kagan, 1983. Cigarette smoke blocks cross-linking of elastin in vitro. Am. Rev. Respir. Dis. 127:189-192.
10. Selby, C., and W. MacNee. 1993. Factors affecting neutrophil transit during acute pulmonary inflammation: minireview. Exp. Lung Res. 19:407-428.
11. MacNee, W., B. Wiggs, A. S. Berzberg, and J. C. Hogg. 1989. The effects of cigarette smoking on neutrophil kinetics in human lungs. N. Engl. J. Med. 321:924-928.
12. Drost, E. M., C. Selby, M. M. E. Bridge-man, and W. MacNee. 1993. Decreased leucocyte deformability after acute cigarette smoking in humans. Am. Rev. Respir. Dis. 148:1277-1283.
13. Klut, M. E., C. M. Doerschuk, J. C. Hogg, S. F. Vaneedon, and A. R. Burns. 1993. Activation of neutrophils within pulmonary microvessels of rabbits exposed to cigarette smoke. Am. J. Respir, Cell Mol. Biol. 9:82-90.
14. Selby, C., E. Drost, D. Brown, S. Howie, and W. MacNee. 1992. Inhibition of neutrophil adherence and movement by acute cigarette smoke exposure. Exp. Lung Res. 18:813-827.
15. Selby, C., E. Drost, S. Lannan, P. K. Wraith, and W. MacNee. 1991. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary diseases. Am. Rev. Respir. Dis. 143:1359-1364.
16. Rahman, I., E. Skwarska, and W. MacNee. 1997. Attenuation of oxidant/ antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52:565-568.
17. Rahman, I., and W. MacNee. 1996. Oxidant/antioxidant imbalance in smokers and in chronic obstructive pulmonary disease, Thorax 51:348-350.
18. Dukhuijzen, R. P. N., K. K. H. Aben, I. Dekker, P. H. J. Aarts, P. M. L. Wielders, L. A. Van Herwaaden, and A. Bast. 1996. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154:813-816.
19. Maziak, W., S. Loukides, S. Culpitt, P. Sullivan, S. A. Kharitonov, and P. J. Barnes. 1998. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157:998-1002.
20. Hoidal, J. R., R. B. Fox, P. A. LeMarbe, R. Perri, and J. E. Repine. 1981. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am. Rev. Respir. Dis. 123:85-89.
21. Pinamonti, S., M. Muzzuli, M. C. Chicca, A. Papi, F. Ravenna, L. M. Fabbri, and A. Ciaccia. 1996. Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive lung disease. Free Radic. Biol. Med. 21:147-155.
22. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione, J. Appl. Physiol. 63:152-157.
23. 2α-III, an index of oxidant stress. Am. J. Respir. Crit. Care Med. 158:1709-1714.
24. Rahman, I., D. Morrison, K. Donaldson, and W. MacNee. 1996. Systemic oxidative stress in asthma, COPD and smokers. Am. J. Respir. Crit. Care Med. 154:1055-1060.
25. Noguera, A., X. Busquets, J. Sauleda, J. M. Villaverde, W. MacNee, and A. G. N. Agusti. 1998. Expression of adhesion molecules and G-proteins in circulating neutrophils in COPD. Am. J. Respir. Crit. Care Med. 158:1664-1668.
26. Brown, D. M., E. Drost, K. Donaldson, and W. MacNee. 1995. Deformability and CD11/CD18 expression of sequestered neutrophils in normal and inflamed lungs. Am. J. Respir. Cell Mol. Biol. 13:531-539.
27. Duthie, G. G., J. R. Arthur, and W. P. T. James. 1991. Effects of smoking and vitamin E on blood antioxidant status. Am. J. Clin. Nutr. 53:1061S-1063S.
28. 2-isoprostanes) in smokers. N. Engl. J. Med. 332:1198-1203.
29. Cross, C. E., C. A. O'Neill, A. Z. Reznick, M. L. Hu, L. Marcocci, L. Packer, and B. Frei. 1993. Cigarette smoke oxidation of human plasma constitutents. Ann. N.Y. Acad. Sci. 686:72-90.
30. Van der Vliet, A., D. Smith, C. A. O'Neill, H. Kaur, V. Darley-Usmar, C. E. Cross, and B. Halliwell. 1994. Interactions of peroxynitrite and human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem. J. 303:295-301.
31. Petruzzelli, S., R. Puntoni, P. Mimotli, N. Pulera, F. Baliva, E. Fornai, and C. Giuntini. 1997. Plasma 3-nitrotyrosine in cigarette smokers. Am. J. Respir. Crit. Care Med. 156:1902 1907.
32. Chan-Yeung, M., and A. Dy Buncio. 1984. Leucocyte count, smoking and lung function. Am. J. Med. 76:31-37.
33. Chan-Yeung, M., R. Abboud, A. Dy Buncio, and S. Vedal. 1988. Peripheral leucocyte count and longitudinal decline in lung function. Thorax 43:426-468.
34. Richards, G. A., A. J. Theron, C. A. van der Merwe, and R. Anderson. 1989. Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes. Am. Rev. Respir. Dis. 139:181-187.
35. Anderson, R., A. J. Theron, G. A. Richards, M. S. Myers, and A. J. V. Rensburg. 1991. Passive smoking by human sensiyizes circulating neutrophils. Am. Rev. Respir. Dis. 144:570-574.
36. Schunemann, H. J., P. Muti, J. L. Freudenheim, D. Armstrong, R. Browne, R. A. Klocke, and M. Trevisan. 1997. Oxidative stress and lung function. Am. J. Epidemiol. 146:939-948.
37. Britton, J. R., I. D. Pavord, K. A. Richards, A. J. Knox, A. F. Wisniewski, S. A. Lewis, A. E. Tatlersfield, and S. T. Weiss. 1995. Dietary antioxidant vitamin intake and lung function in the general population. Am. J. Respir. Crit. Care Med. 151:1383 1387.
38. Steinberg, F. M., and A. Chait. 1998. Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am. J. Clin. Nutr. 68:319-327.
39. Keating, V. M., P. D. Collins, D. M. Scott, and P. J. Barnes, 1996. Differences in interleukin-8 and turmor necrosis factor-induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153:530-534.
40. Rahman, I., and W. MacNee. 1998. Role of transcription factors in inflammatory lung diseases, Thorax 53:601-612.
41. Parmentier, M., E. Drost, N. Hirani, I. Rahman, K. Donaldson, W. MacNee, and K Antonicelli. 1994. Thiol antoxidants inhibit neutrophil chemotaxis by decreasing release of IL-8 from macrophages and pulmonary epithelial cells (abstract). Am. J. Respir. Crit. Care Med. 159:A27.
42. Rahman, I., X. Y. Li, K. Donaldson, D. J. Harrison, and W. MacNee. 1995. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am. J Physiol. Lung Cell Mol. Physiol. 13:L285-L292.
43. Li, X. Y., I. Rahman, K. Donaldson, and W. MacNee. 1996. Mechanisms of cigarette smoke induced increased airspace permeability. Thorax 51:465-471.
44. Li, X. Y., K. Donaldson, I. Rahman, and W. MacNee. 1994. An investigation of the mechanism of the increased epithelial permeability induced by cigarette smoke in vivo and in vitro models. Am. J. Respir. Crit. Care Med. 149:1518-1525.
45. Rahman, I., M. F. Lawson, C. A. D. Smith, C. J. Harrison, and W. MacNee. 1996. Induction of-γ-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett. 396:21-25.
46. Rahman, I., A. Bel, B. Mulier, M. F. Lawson, D. J. Harrison, W. MacNee, and C. A. C. Smith. 1996. Transcriptional regulation of γ-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem. Biophys. Res. Commun. 229:832-837.
47. Rahman, I., C. A. D. Smith, F. Amonicelli, and W. MacNee. 1998. Characterisation of γ-glutamylcysteine-heavy subunit gene promoter: critical role for AP-1. FEBS Lett. 427:129-133.
48. Rahman, I., F. Antonicelli, and W. MacNee. 1999. Molecular mechanisms of the regulation of glutathione synthesis by tumour necrosis factor-α and dcxamethasone in human alveolar epithelial cells. J. Biol. Chem. 274:5088-5096.
49. Gilks, C. B., K. Price, J. L. Wright, and A. Churg. 1998. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am. J. Pathol. 152:269-278.
50. Muller, T., and S. Gebel. 1998. The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration. Carcinogenesis 19:797-801.
51. Sandford, A. J., T. D. Weir, and P. D. Pare. 1997. Genetic risk factors for chronic obstructive pulmonary disease. Eur. Respir. J. 10:1380-1391.
52. Smith, C. A. D., and D. J. Harrison. 1997. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630-633.
53. MacNee, W., M. M. F. Bridgeman, M. Marsden, E. Drost, S. Lannan, C. Selby, and K. Donaldson. 1991. The effects of N-acetylcysteine and glutathione on smoke-induced changes in lung phagocytes and epithelial cells. Am. J. Med. 90:60s-66s.
54. Marrades, R. M., J. Roca, J. Barbera, L. de Jover, W. MacNee, and R. Rodriguez-Roisin. 1997. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am. J. Respir. Crit. Care Med. 156:425-430.
55. Bridgeman, M. M. E., M. Marsden, C. Selby, D. Morrison, and W. MacNee. 1994. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid and lining tissue. Thorax 49:670-675.
56. Bowman, G., U. Backer, S. Larsson, B. Melander, and L. Wahlander. 1983. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis. Eur. J. Respir. Du. 64:405-415.
57. British Thoracic Society Research Committee. 1985. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. Thorax 40:823-835.
58. Gillissen, A., M. Jaworska, M. Orth, M Coffiner, P. Maes, E. M. App, A. M. Cantin, and G. Schultze-Werninghaus. 1997. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir. Med. 91:159-168.
59. Nagy, A. M., F. Vanderbist, N. Parij, P. Maes, P. Fondu, and J. Neve. 1997. Effect of the mucoactive drug Nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils. Pulm. Pharmacol. Ther. 10:287-292.
60. Tsan, M., J. E. White, and C. L. Rosano. 1989. Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester. J. Appl. Physiol. 66:1029-1034.
61. Tsan, M. F., and P. G. Phillips. 1988. L-2-Oxothiazolidine-4-carboxylate protects cultured endothelial cells against hyperoxia-induced injury. Inflammation 12:113-121.